James Robinson will become Alkermes plc's president and COO on March 5.
He will lead the Dublin-based company's global commercial, business development and human resources functions as it expands its commercial portfolio to advance treatments for central nervous system disorders.
Robinson was previously the president of Americas operations at Astellas US LLC, a subsidiary of Astellas Pharma Inc.
He has more than 25 years of biopharmaceutical industry experience.
